Letter: Albumin-Does formulation matter? Authors' reply
- PMID: 37243460
- DOI: 10.1111/apt.17546
Letter: Albumin-Does formulation matter? Authors' reply
Comment on
-
Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis.Aliment Pharmacol Ther. 2023 Mar;57(6):620-634. doi: 10.1111/apt.17344. Epub 2022 Dec 15. Aliment Pharmacol Ther. 2023. PMID: 36524316
-
Letter: Albumin-Does formulation matter?Aliment Pharmacol Ther. 2023 Jun;57(12):1482-1483. doi: 10.1111/apt.17531. Aliment Pharmacol Ther. 2023. PMID: 37243466 No abstract available.
References
REFERENCES
-
- Yu C, Iqbal A, Garg M, Sood S, Lewis D. Letter: albumin-does formulation matter? Aliment Pharmacol Ther. 2023;57:1482-3.
-
- Leache L, Gutiérrez-Valencia M, Saiz LC, Uriz J, Bolado F, García-Erce JA, et al. Meta-analysis: efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis. Aliment Pharmacol Ther. 2023;57(6):620-34. https://doi.org/10.1111/APT.17344
-
- Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70(1):9-29. https://doi.org/10.1136/GUTJNL-2020-321790
-
- Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-60. https://doi.org/10.1016/j.jhep.2018.03.024
-
- Gentilini P, Casini-Raggi V, Di FG, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol. 1999;30(4):639-45. https://doi.org/10.1016/S0168-8278(99)80194-9